Serine protease inhibition reduces post-ischemic granulocyte recruitment in mouse intestine

American Journal of Pathology

Volumn 180, Issue 1, 2012, Pages 141-152

  Gobbetti, Thomas ^a,b,c,d   Cenac, Nicolas ^a,b,c   Motta, Jean Paul ^a,b,c   Rolland, Corinne ^a,b,c   Martin, Laurence ^a,b,c   Andrade Gordon, Patricia ^e   Steinhoff, Martin ^f   Barocelli, Elisabetta ^d   Vergnolle, Nathalie ^a,b,c,g  

^a INSERM   (France)

^b CNRS   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d UNIVERSITY OF PARMA   (Italy)

^e JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; MYELOPEROXIDASE; NAFAMSTAT MESILATE; PROTEINASE ACTIVATED RECEPTOR; SERINE PROTEINASE INHIBITOR; TRYPSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; INTESTINE INJURY; INTESTINE ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REPERFUSION INJURY; SURVIVAL RATE; WESTERN BLOTTING;

ALPHA-MACROGLOBULINS; ANIMALS; CHEMOKINES; CYSTEINE PROTEINASE INHIBITORS; GRANULOCYTES; GUANIDINES; INTESTINE, SMALL; ISCHEMIA; LEUCINE; MALE; MICE; MICE, INBRED C57BL; PEROXIDASE; PROTEASE INHIBITORS; RECEPTOR, PAR-1; RECEPTOR, PAR-2; REPERFUSION INJURY; SERINE PROTEINASE INHIBITORS; TRYPSIN;

EID: 83455200396     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.09.031     Document Type: Article

References (61)

1. C.D. Collard, S. Gelman Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury Anesthesiology 94 2001 1133 1138 (Pubitemid 32506143)
2. I.H. Mallick, W. Yang, M.C. Winslet, A.M. Seifalian Ischemia-reperfusion injury of the intestine and protective strategies against injury Dig Dis Sci 49 2004 1359 1377 (Pubitemid 39273608)
3. W.A. Oldenburg, L.L. Lau, T.J. Rodenberg, H.J. Edmonds, C.D. Burger Acute mesenteric ischemia: a clinical review Arch Intern Med 164 2004 1054 1062 (Pubitemid 38668984)
4. P.A. Van Leeuwen, M.A. Boermeester, A.P. Houdijk, C.C. Ferwerda, M.A. Cuesta, S. Meyer, R.I. Wesdorp Clinical significance of translocation Gut 35 1994 S28 S34
5. N.F. Cerqueira, C.A. Hussni, W.B. Yoshida Pathophysiology of mesenteric ischemia/reperfusion: a review Acta Cir Bras 20 2005 336 343
6. M. Gatt, B.S. Reddy, J. MacFie Review article: bacterial translocation in the critically ill: evidence and methods of prevention Aliment Pharmacol Ther 25 2007 741 757 (Pubitemid 46437210)
7. N. Vergnolle Proteinase-activated receptors (PARs) in infection and inflammation in the gut Int J Biochem Cell Biol 40 2008 1219 1227
8. N. Vergnolle Protease-activated receptors as drug targets in inflammation and pain Pharmacol Ther 123 2009 292 309
9. N. Vergnolle Clinical relevance of proteinase activated receptors (PARs) in the gut Gut 54 2005 867 874 (Pubitemid 40732107)
10. N. Vergnolle, M. Ferazzini, M.R. D'Andrea, J. Buddenkotte, M. Steinhoff Proteinase-activated receptors: novel signals for peripheral nerves Trends Neurosci 26 2003 496 500 (Pubitemid 37025788)
11. N. Vergnolle Review article: proteinase-activated receptorsnovel signals for gastrointestinal pathophysiology Aliment Pharmacol Ther 14 2000 257 266 (Pubitemid 30145312)
12. N. Vergnolle, J.L. Wallace, N.W. Bunnett, M.D. Hollenberg Protease-activated receptors in inflammation, neuronal signaling and pain Trends Pharmacol Sci 22 2001 146 152 (Pubitemid 32181845)
13. S. Houle, M.D. Papez, M. Ferazzini, M.D. Hollenberg, N. Vergnolle Neutrophils and the kallikrein-kinin system in proteinase-activated receptor 4-mediated inflammation in rodents Br J Pharmacol 146 2005 670 678 (Pubitemid 41573618)
14. N. Vergnolle, M.D. Hollenberg, K.A. Sharkey, J.L. Wallace Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR-2)-activating peptides in the rat paw Br J Pharmacol 127 1999 1083 1090 (Pubitemid 29326629)
15. N. Vergnolle, M.D. Hollenberg, J.L. Wallace Pro- and anti-inflammatory actions of thrombin: a distinct role for proteinase-activated receptor-1 (PAR1) Br J Pharmacol 126 1999 1262 1268 (Pubitemid 29123764)
16. N. Cenac, L. Cellars, M. Steinhoff, P. Andrade-Gordon, M.D. Hollenberg, J.L. Wallace, S. Fiorucci, N. Vergnolle Proteinase-activated receptor-1 is an anti-inflammatory signal for colitis mediated by a tpe 2 immune response Inflamm Bowel Dis 11 2005 792 798 (Pubitemid 41368266)
17. N. Cenac, A.M. Coelho, C. Nguyen, S. Compton, P. Andrade-Gordon, W.K. MacNaughton, J.L. Wallace, M.D. Hollenberg, N.W. Bunnett, R. Garcia-Villar, L. Bueno, N. Vergnolle Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2 Am J Pathol 161 2002 1903 1915 (Pubitemid 35265547)
18. M. Ferazzini, S. Santi, W.K. Macnaughton, M.D. Hollenberg, J.L. Wallace, N. Vergnolle Proteinase-activated receptor-4 (PAR4) is implicated in the pathogenesis of dextran sodium sulfate colitis (abstract) Gastroenterology 2003 A-487124
19. C. Nguyen, A.M. Coelho, E. Grady, S.J. Compton, J.L. Wallace, M.D. Hollenberg, N. Cenac, R. Garcia-Villar, L. Bueno, M. Steinhoff, N.W. Bunnett, N. Vergnolle Colitis induced by proteinase-activated receptor-2 agonists is mediated by a neurogenic mechanism Can J Physiol Pharmacol 81 2003 920 927 (Pubitemid 37188271)
20. N. Vergnolle, L. Cellars, A. Mencarelli, G. Rizzo, S. Swaminathan, P. Beck, M. Steinhoff, P. Andrade-Gordon, N.W. Bunnett, M.D. Hollenberg, J.L. Wallace, G. Cirino, S. Fiorucci A role for proteinase-activated receptor-1 in inflammatory bowel diseases J Clin Invest 114 2004 1444 1456 (Pubitemid 40385575)
21. A.C. Chin, W.Y. Lee, A. Nusrat, N. Vergnolle, C.A. Parkos Neutrophil-mediated activation of epithelial protease-activated receptors-1 and -2 regulates barrier function and transepithelial migration J Immunol 181 2008 5702 5710
22. N. Shimoda, N. Fukazawa, K. Nonomura, R.L. Fairchild Cathepsin G is required for sustained inflammation and tissue injury after reperfusion of ischemic kidneys Am J Pathol 170 2007 930 940 (Pubitemid 47339362)
23. A.J. Fowell, R.C. Benyon Can matrix metalloproteinases be targeted in hepatic ischemia/reperfusion injury? Hepatology 47 2008 14 16 (Pubitemid 351171036)
24. Y. Uchida, M.C. Freitas, D. Zhao, R.W. Busuttil, J.W. Kupiec-Weglinski The inhibition of neutrophil elastase ameliorates mouse liver damage due to ischemia and reperfusion Liver Transpl 15 2009 939 947
25. M. Donato, V. D'Annunzio, B. Buchholz, V. Miksztowicz, C.L. Carrion, L.B. Valdez, T. Zaobornyj, L. Schreier, R. Wikinski, A. Boveris, G. Berg, R.J. Gelpi Role of matrix metalloproteinase-2 in the cardioprotective effect of ischaemic postconditioning Exp Physiol 95 2010 274 281
26. H. Schwertz, J.M. Carter, M. Russ, S. Schubert, A. Schlitt, U. Buerke, M. Schmidt, H. Hillen, K. Werdan, M. Buerke Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition J Cardiovasc Pharmacol 52 2008 151 160
27. F. Calcina, C. Sternini, P. Ghizzardi, F. Cattaruzza, S. Bertoni, V. Ballabeni, M. Impicciatore, E. Barocelli Protective effects of a protease inhibitor (gabexate mesilate) on intestinal ischemia/reperfusion injury in rats (abstract) Gastroenterology 126 2004 A256
28. K. Ishimaru, H. Mitsuoka, N. Unno, K. Inuzuka, S. Nakamura, G.W. Schmid-Schonbein Pancreatic proteases and inflammatory mediators in peritoneal fluid during splanchnic arterial occlusion and reperfusion Shock 22 2004 467 471 (Pubitemid 39472572)
29. M. Steinhoff, N. Vergnolle, S.H. Young, M. Tognetto, S. Amadesi, H.S. Ennes, M. Trevisani, M.D. Hollenberg, J.L. Wallace, G.H. Caughey, S.E. Mitchell, L.M. Williams, P. Geppetti, E.A. Mayer, N.W. Bunnett Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism Nat Med 6 2000 151 158 (Pubitemid 30082358)
30. N. Vergnolle, N.W. Bunnett, K.A. Sharkey, V. Brussee, S.J. Compton, E.F. Grady, G. Cirino, N. Gerard, A.I. Basbaum, P. Andrade-Gordon, M.D. Hollenberg, J.L. Wallace Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway Nat Med 7 2001 821 826 (Pubitemid 32691637)
31. J.P. Motta, L. Magne, D. Descamps, C. Rolland, C. Squarzoni-Dale, P. Rousset, L. Martin, N. Cenac, V. Balloy, M. Huerre, D. Jenne, J. Wartelle, A. Belaaouaj, E. Mas, J.P. Vinel, L. Alric, M. Chignard, N. Vergnolle, J.M. Sallenave Modifying the protease, antiprotease pattern by elafin overexpression protects mice from colitis Gastroenterology 140 2011 1272 1282
32. N. Cenac, C.N. Andrews, M. Holzhausen, K. Chapman, G. Cottrell, P. Andrade-Gordon, M. Steinhoff, G. Barbara, P. Beck, N.W. Bunnett, K.A. Sharkey, J.G. Ferraz, E. Shaffer, N. Vergnolle Role for protease activity in visceral pain in irritable bowel syndrome J Clin Invest 117 2007 636 647 (Pubitemid 46348522)
33. A. Sarin, D.H. Adams, P.A. Henkart Protease inhibitors selectively block T cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T cells J Exp Med 178 1993 1693 1700 (Pubitemid 23318448)
34. A.J. Barrett, A.A. Kembhavi, M.A. Brown, H. Kirschke, C.G. Knight, M. Tamai, K. Hanada L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L Biochem J 201 1982 189 198 (Pubitemid 12038477)
35. S. Murao, K. Ohkuni, M. Nagao, K. Hirayama, K. Fukuhara, K. Oda, H. Oyama, T. Shin Purification and characterization of kumamolysin, a novel thermostable pepstatin-insensitive carboxyl proteinase from Bacillus novosp MN-32 J Biol Chem 268 1993 349 355 (Pubitemid 23021328)
36. W.B. Lawson, V.B. Valenty, J.D. Wos, A.P. Lobo Studies on the inhibition of human thrombin: effects of plasma and plasma constituents Folia Haematol Int Mag Klin Morphol Blutforsch 109 1982 52 60 (Pubitemid 12161235)
37. F. Markwardt, J. Drawert, P. Walsmann Synthetic low molecular weight inhibitors of serum kallikrein Biochem Pharmacol 23 1974 2247 2256
38. F. Cattaruzza, N. Cenac, E. Barocelli, M. Impicciatore, E. Hyun, N. Vergnolle, C. Sternini Protective effect of proteinase-activated receptor 2 activation on motility impairment and tissue damage induced by intestinal ischemia/reperfusion in rodents Am J Pathol 169 2006 177 188
39. E. D'Aldebert, N. Cenac, P. Rousset, L. Martin, C. Rolland, K. Chapman, J. Selves, L. Alric, J.P. Vinel, N. Vergnolle Transient receptor potential vanilloid 4 activated inflammatory signals by intestinal epithelial cells and colitis in mice Gastroenterology 140 2011 275 285
40. N. Cenac, C. Altier, J.P. Motta, E. d'Aldebert, S. Galeano, G.W. Zamponi, N. Vergnolle Potentiation of TRPV4 signalling by histamine and serotonin: an important mechanism for visceral hypersensitivity Gut 59 2010 481 488
41. N. Cenac, C. Altier, K. Chapman, W. Liedtke, G. Zamponi, N. Vergnolle Transient receptor potential vanilloid-4 has a major role in visceral hypersensitivity symptoms Gastroenterology 135 2008 937 946
42. T. Aoyama, Y. Ino, M. Ozeki, M. Oda, T. Sato, Y. Koshiyama, S. Suzuki, M. Fujita Pharmacological studies of FUT-175, nafamstat mesilate I Inhibition of protease activity in in vitro and in vivo experiments Jpn J Pharmacol 35 1984 203 227 (Pubitemid 14124814)
43. M. Perretti, S.J. Getting Migration of specific leukocyte subsets in response to cytokine or chemokine application in vivo Methods Mol Biol 225 2003 139 146
44. G.S. Cottrell, S. Amadesi, E.F. Grady, N.W. Bunnett Trypsin IV, a novel agonist of protease-activated receptors 2 and 4 J Biol Chem 279 2004 13532 13539 (Pubitemid 38468878)
45. N. Koshikawa, S. Hasegawa, Y. Nagashima, K. Mitsuhashi, Y. Tsubota, S. Miyata, Y. Miyagi, H. Yasumitsu, K. Miyazaki Expression of trypsin by epithelial cells of various tissues, leukocytes, and neurons in human and mouse Am J Pathol 153 1998 937 944 (Pubitemid 28419046)
46. N. Koshikawa, Y. Nagashima, Y. Miyagi, H. Mizushima, S. Yanoma, H. Yasumitsu, K. Miyazaki Expression of trypsin in vascular endothelial cells FEBS Lett 409 1997 442 448 (Pubitemid 27285902)
47. D.A. Lawrence, D.J. Loskutoff Inactivation of plasminogen activator inhibitor by oxidants Biochemistry 25 1986 6351 6355 (Pubitemid 17217879)
48. T.W. Stief, P. Lenz, U. Becker, N. Heimburger Determination of plasminogen activator inhibitor (PAI) capacity of human plasma in presence of oxidants: a novel principle Thromb Res 50 1988 559 573
49. T.W. Stief, A. Aab, N. Heimburger Oxidative inactivation of purified human alpha-2-antiplasmin, antithrombin III, and C1-inhibitor Thromb Res 49 1988 581 589
50. T.W. Stief, N. Heimburger Inactivation of serine proteinase inhibitors (serpins) in human plasma by reactive oxidants Biol Chem Hoppe Seyler 369 1988 1337 1342 (Pubitemid 19017809)
51. T.W. Stief, J. Kropf, V. Kretschmer, M.O. Doss, J. Fareed Singlet oxygen ((1)O2) inactivates plasmatic free and complexed alpha2-macroglobulin Thromb Res 98 2000 541 547 (Pubitemid 30433782)
52. Z. Sun, X. Wang, X. Deng, A. Lasson, R. Wallen, E. Hallberg, R. Andersson The influence of intestinal ischemia and reperfusion on bidirectional intestinal barrier permeability, cellular membrane integrity, proteinase inhibitors, and cell death in rats Shock 10 1998 203 212 (Pubitemid 128464311)
53. K. Olanders, Z. Sun, A. Borjesson, M. Dib, E. Andersson, A. Lasson, T. Ohlsson, R. Andersson The effect of intestinal ischemia and reperfusion injury on ICAM-1 expression, endothelial barrier function, neutrophil tissue influx, and protease inhibitor levels in rats Shock 18 2002 86 92
54. A. Pierro, S. Eaton Intestinal ischemia reperfusion injury and multisystem organ failure Semin Pediatr Surg 13 2004 11 17 (Pubitemid 38233854)
55. A.M. Lefer The pathophysiologic role of myocardial depressant factor as a mediator of circulatory shock Klin Wochenschr 60 1982 713 716 (Pubitemid 12092117)
56. H. Wang, F. Moreau, C.L. Hirota, W.K. MacNaughton Proteinase-activated receptors induce interleukin-8 expression by intestinal epithelial cells through ERK/RSK90 activation and histone acetylation FASEB J 24 2010 1971 1980
57. Y. Tanaka, F. Sekiguchi, H. Hong, A. Kawabata PAR2 triggers IL-8 release via MEK/ERK and PI3-kinase/Akt pathways in GI epithelial cells Biochem Biophys Res Commun 377 2008 622 626
58. E. Hyun, P. Andrade-Gordon, M. Steinhoff, P.L. Beck, N. Vergnolle Contribution of bone marrow-derived cells to the pro-inflammatory effects of protease-activated receptor-2 in colitis Inflamm Res 59 2010 699 709
59. E. Hyun, P. Andrade-Gordon, M. Steinhoff, N. Vergnolle Protease-activated receptor-2 activation: a major actor in intestinal inflammation Gut 57 2008 1222 1229
60. E. Hyun, R. Ramachandran, N. Cenac, S. Houle, P. Rousset, A. Saxena, R.S. Liblau, M.D. Hollenberg, N. Vergnolle Insulin modulates protease-activated receptor 2 signaling: implications for the innate immune response J Immunol 184 2010 2702 2709
61. A. Rahman, A.L. True, K.N. Anwar, R.D. Ye, T.A. Voyno-Yasenetskaya, A.B. Malik Galpha and Gbetagamma regulate PAR-1 signaling of thrombin-induced NF-kappaB activation and ICAM-1 transcription in endothelial cells Circ Res 91 2002 398 405 (Pubitemid 35034207)